Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
62 hedge funds and large institutions have $423M invested in Icosavax, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 12 closing their positions.
117% more capital invested
Capital invested by funds: $195M → $423M (+$228M)
100% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 14
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
8% more call options, than puts
Call options by funds: $461K | Put options by funds: $428K
6% less funds holding
Funds holding: 66 → 62 (-4)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$29.6M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$17.3M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$13.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.73M |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$917K |
| 3 |
Two Sigma Investments
New York
|
-$603K |
| 4 |
Millennium Management
New York
|
-$432K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$405K |
ICVX Hedge Fund Activity: Q2 2023 in Review
62 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q2 2023, worth a combined $423M — up 117% from $195M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ICVX and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 28 added.
The largest buyer was TCG Crossover Management, opening a new position worth an estimated $29.6M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $3.73M sold.
- 62 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q2 2023, down from 66 in Q1 2023.
- Funds reported $423M of Icosavax, Inc. Common Stock stock for Q2 2023, up 117% quarter-over-quarter.
- 9 funds opened new Icosavax, Inc. Common Stock positions in Q2 2023 and 12 closed out, a net change of -3 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q2 2023 was TCG Crossover Management, an estimated $29.6M added.
- The largest Icosavax, Inc. Common Stock seller in Q2 2023 was Cormorant Asset Management, an estimated $3.73M sold.
Based on aggregated 13F filings for Q2 2023.